The role of mouse models in translational cancer research: present and future directions

Submitted: 25 January 2017
Accepted: 18 July 2017
Published: 7 November 2017
Abstract Views: 1152
PDF: 417
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

A major issue in the research for new anticancer therapeutics is represented by the low number of new compounds approved for clinical use in comparison to the good success rate reported in preclinical studies. This high attrition rate could be attributed to many factors including the unsatisfactory predictive value of experiments performed in animals. To this purpose, general opinions suggest that classical models as murine tumors and xenografts do not mimic the complexity of human cancer diseases and that the use and integration of different relevant mouse models could improve the efficiency of the drug development process. In this review, we overview the present state of research in the field of mouse models for cancer and describe the advantages and limitations of the different models. Finally, strategies for improving the predictive value of animal experiments will be also discussed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

Regina Elena National Cancer Institute, rome, Italy. Italian Association for Cancer Research (AIRC)

How to Cite

Porru, M., & Leonetti, C. (2017). The role of mouse models in translational cancer research: present and future directions. Translational Medicine Reports, 4(1). https://doi.org/10.4081/tmr.6598